MedTrace Logo

Mentholated Cream Containing Oxygenated Glycerol Triesters on Acute Pain of the Muscles and Joints

NCT01387750 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2011-07-06

No results posted yet for this study

Summary

A single center trial to evaluate the efficacy, tolerance, and acceptability of Oxygenated Glycerol Triesters (OGT) mentholated cream on acute musculoskeletal pain in normal healthy adult volunteers suffering from a recent inflammation of muscles and joints. Patient who met eligibility requirements were instructed to identify one area on their body where they were experiencing the most acute musculoskeletal pain/discomfort. Patients were provided with visual analog scales in order to quantify their pain. Patients either received mentholated cream with or without OGT and instructed to rub on the identified site 3 times a day for 7 days. Pain and other observations were written in a diary for each day.

Conditions

Interventions

OTHER

Mentholated Cream

A topical cream containing menthol without the addition of the oxygenated glycerol triesters.

OTHER

Mentholated Cream with OGT

A Topical Cream that contained both menthol and oxygenated glycerol triesters.

Sponsors & Collaborators

  • Laboratories Carilene

    collaborator UNKNOWN

  • NEMA Research, Inc.

    lead INDUSTRY

Principal Investigators

  • Barry T Reece, MS, MBA · RCTS, Inc.

  • Jessica Williams, BS · RCTS, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2007-06-30
Completion
2007-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01387750 on ClinicalTrials.gov